Pancreatic Cancer Research

ResearcherCentral South UniversityNo recent work listed

Weijia Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8268-3313; OpenAlex author ID A5101810482. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 3

  1. Identification of significant prognostic risk markers for pancreatic ductal adenocarcinoma: a bioinformatic analysis. First author DOI 10.18388/abp.2020_5758↗
  2. MiR-29c inhibits cell growth, invasion, and migration of pancreatic cancer by targeting ITGB1. Co-author DOI 10.2147/ott.s92758↗
  3. Reduced STMN1 expression induced by RNA interference inhibits the bioactivity of pancreatic cancer cell line Panc-1. Last author DOI 10.4149/neo_2014_020↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhipeng Zhang · 1 shared paper, 2022 · strength 0.22
  2. Yebin Lu · 1 shared paper, 2022 · strength 0.22
  3. Yebin Lu · 1 shared paper, 2016 · strength 0.07
  4. Ming Li · 1 shared paper, 2016 · strength 0.07
  5. Guo‐Huang Hu · 1 shared paper, 2014 · strength 0.05
  6. Juan Li · 1 shared paper, 2014 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.